p53-independent apoptosis: A mechanism of radiation-induced cell death of glioblastoma cells

Cancer Journal from Scientific American

Volumn 2, Issue 2, 1996, Pages 114-121

  Haas Kogan, Daphne A ^a   Dazin, Paul ^b   Hu, Lily ^a   Deen, Dennis F ^a   Israel, Mark A ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Apoptosis; DNA damage; G1 arrest; Glioblastoma; p53

Indexed keywords

PROTEIN P53;

APOPTOSIS; ARTICLE; CELL CYCLE; FLOW CYTOMETRY; GLIOBLASTOMA; HUMAN; IN VITRO STUDY; METABOLISM; PHYSIOLOGY; RADIATION DOSE; RADIATION EXPOSURE; TUMOR CELL LINE; WESTERN BLOTTING;

APOPTOSIS; BLOTTING, WESTERN; CELL CYCLE; CELL LINE, TUMOR; FLOW CYTOMETRY; GLIOBLASTOMA; HUMANS; RADIATION TOLERANCE; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0000262666     PISSN: 10814442     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (60)

1. Fults D, Brockmeyer D, Tullous MW, Pedone C, Cawthon RM. p53 mutation and loss of heterozygosity on chromosomes 17 and 10 during human astrocytoma progression. Cancer Res 1992;52:674-679.
2. Frankel R, Bayona W, Koslow M, Newcomb EW. p53 mutations in human malignant gliomas: comparison of loss of heterozygosity with mutation frequency. Cancer Res 1992;52:1427-1433.
3. McKay RD. The origins of cellular diversity in the mammalian central nervous system. Cell 1989;58:815-821.
4. Sheline GE. Radiation therapy of brain tumors. Cancer 1977;39:873-881.
5. Chang CH, Horton J, Schoenfeld D et al. Comparison of postoperative radiotherapy and combined postoperative radiotherapy and chemotherapy in the multidisciplinary management of malignant gliomas. A joint Radiation Therapy Oncology Group and Eastern Cooperative Oncology Group study. Cancer 1983;52:997-1007.
6. Ludgate CM, Douglas BG, Dixon PF, Steinbok P, Jackson SM, Goodman GB. Superfractionated radiotherapy in grade III, IV intracranial gliomas. Int J Radiat Oncol Biol Phys 1988;15:1091-1095.
7. Leibel SA, Sheline GE. Radiation therapy for neoplasms of the brain. J Neurosurg 1987;66:1-22.
8. Taghian A, Suit H, Pardo F et al. In vitro intrinsic radiation sensitivity of glioblastoma multiforme. Int J Radiat Oncol Biol Phys 1992;23:55-62.
9. Gerweck LE, Kornblith PL, Burlett P, Wang J, Sweigert S. Radiation sensitivity of cultured human glioblastoma cells. Radiology 1977;125:231-234.
10. Denekamp J. Cell kinetics and radiation biology. Int J Radiat Biol Relat Stud Phys Chem Med 1986;49:357-380.
11. Painter RB, Young BR. Radiosensitivity in ataxia-telangiectasia: a new explanation. Proc Natl Acad Sci USA 1980;77:7315-7317.
12. Weinert TA, Hartwell LH. The RAD9 gene controls the cell cycle response to DNA damage in Saccharomyces cerevisiae. Science 1988;241:317-322.
13. Hartwell LH, Weinert TA. Checkpoints: controls that ensure the order of cell cycle events. Science 1989;2466:629-634.
14. Price A. The repair of ionising radiation-induced damage to DNA. Semin Cancer Biol 1993;4:61-71.
15. Kuerbitz SJ, Plunkett BS, Walsh WV, Kastan MB. Wild-type p53 is a cell cycle checkpoint determinant following irradiation. Proc Natl Acad Sci USA 1992;89:7491-7495.
16. Kastan MB, Onyekwere O, Sidransky D, Vogelstein B, Craig RW. Participation of p53 protein in the cellular response to DNA damage. Cancer Res 1991;51:6304-6311.
17. Kastan MB, Zhan Q, el-Deiry WS et al. A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia. Cell 1992;71:587-597.
18. Weichselbaum RR. Cellular and molecular aspects of human tumor radioresistance. Important Adv Oncol 1991;73-83.
19. Hall EJ, Hall EJ. Radiobiology for the Radiologist. Philadelphia: J.B. Lippincott, 1988:138-160.
20. Tolmach LJ, Jones RW, Busse PM. The action of caffeine on X-irradiated HeLa cells. I. Delayed inhibition of DNA synthesis. Radiat Res 1977;71:653-665.
21. Lowe SW, Ruley HE, Jacks T, Housman DE. p53-Dependent apoptosis modulates the cytotoxicity of anitcancer agents. Cell 1993a;74:957-967.
22. Lowe SW, Schmitt EM, Smith SW, Osborne BA, Jacks T. p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature 1993b;362:847-849.
23. Mercer WE, Shields MT, Amin M et al. Negative growth regulation in a glioblastoma tumor cell line that conditionally expresses human wild-type p53. Proc Natl Acad Sci USA 1990;87:6166-6170.
24. Michalovitz D, Halevy O, Oren M. Conditional inhibition of transformation and of cell proliferation by a temperature-sensitive mutant of p53. Cell 1990;62:671-680.
25. Diller L, Kassel J, Nelson CE et al. p53 functions as a cell cycle control protein in osteosarcomas. Mol Cell Biol 1990;10:5772-5781.
26. Baker SJ, Markowitz S, Fearon ER, Willson J, Vogelstein B. Suppression of human colorectal carcinoma cell growth by wild-type p53. Science 1990;249:912-915.
27. Shaulsky G, Goldfinger N, Peled A, Rotter V. Involvement of wild-type p53 in pre-B-cell differentiation in vitro. Proc Natl Acad Sci USA 1991;88:8982-8986.
28. Yonish-Rouach E, Resnitzky D, Lotem J, Sachs L, Kimchi A, Oren M. Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6. Nature 1991;352:345-347.
29. Clarke AR, Purdie CA, Harrison DJ et al. Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature 1993;362:849-852.
30. Oppenheim RW. Cell death during development of the nervous system. Annu Rev Neurosci 1991;14:453-501.
31. Golstein P, Ojcius DM, Young JD. Cell death mechanisms and the immune system. Immunol Rev 1991;121:29-65.
32. Cohen JJ, Duke RC, Fadok VA, Sellins KS. Apoptosis and programmed cell death in immunity. Annu Rev Immunol 1992;10:267-93.
33. Rothenberg EV. The development of functionally responsive T cells. Adv Immunol 1992;51:85-214.
34. Clem RJ, Fechheimer M, Miller LK. Prevention of apoptosis by a baculovirus gene during infection of insect cells. Science 1991;254:1388-1390.
35. Hershberger PA, Dickson JA, Friesen PD. Site-specific mutagenesis of the 35-kilodalton protein gene encoded by Autographa californica nuclear polyhedrosis virus: cell line-specific effects on virus replication. J Virol 1992;66:5525-5533.
36. Rao L, Debbas M, Sabbatini P, Hockenbery D, Korsmeyer S, White E. The adenovirus E1A proteins induce apoptosis, which is inhibited by the E1B 19-kDa and Bcl-2 proteins. Proc Natl Acad Sci USA 1992;89:7742-7746.
37. Xia F, Wang X, Wang YH et al. Altered p53 status correlates with differences in sensitivity to radiation-induced mutation and apoptosis in two closely related human lymphblast lines. Cancer Res 1995;55:12-15.
38. Seki H, Kangane H, Iwai K et al. Ionizing radiation induces apoptotic cell death in human TcR-gamma/delta+ T and natural killer cells without detectable p53 protein. Eur J Immunol 1994;24:2914-2917.
39. Haas-Kogan DA, Kogan SC, Levi D et al. Inhibition of apoptosis by the retinoblastoma gene product. EMBO J 1995;14:461-472.
40. Strasser A, Harris AW, Jacks T, Cory S. DNA damage can induce apoptosis in proliferating lymphoid cells via p53-independent mechanisms inhibitable by Bcl-2. Cell 1994;79:329-339.
41. LaRocca RV, Rosenblum M, Westermark B, Israel MA. Patterns of proto-oncogene expression in human glioma cell lines. J Neurosci Res 1989;24:97-106.
42. Dive C, Gregory CD, Phipps DJ, Evans DL, Milner AE, Wyllie AH. Analysis and discrimination of necrosis and apoptosis (programmed cell death) by multiparameter flow cytometry. Biochim Biophys Acta 1992;1133:275-285.
43. Fairbairn LJ, Cowling GJ, Reipert BM, Dexter TM. Suppression of apoptosis allows differentiation and development of a multipotent hemopoietic cell line in the absence of added growth factors. Cell 1993;74:823-832.
44. Darzynkiewicz Z, Bruno S, Del Bino G et al. Features of apoptotic cells measured by flow cytometry. Cytometry 1992;13:795-808.
45. Sarkar A, Dolan ME, Gonzalez GG, Marton LJ, Pegg AE, Deen DF. The effects of o6-benzylguanine and hypoxia on the cytotoxicity of 1,3-bis(chloroethyl)-1-nitrosourea in nitrosourea-resistant SF-763 cells. Cancer Chemother Pharmacol 1993;32:477-481.
46. Fertil B, Malaise EP. Intrinsic radiosensitivity of human cell lines is correlated with radioresponsiveness of human tumors: analysis of 101 published survival curves. Int J Radiat Oncol Biol Phys 1985;11:1699-1707.
47. Albright N. Computer programs for the analysis of cellular survival data. Radiat Res 1987;112:331-340.
48. Gregory CD, Dive C, Henderson S et al. Activation of Epstein-Barr virus latent genes protects human B cells from death by apoptosis. Nature 1991;349:612-614.
49. Stephens LC, Ang KK, Schultheiss TE, Milas L, Meyn RE. Apoptosis in irradiated murine tumors. Radiat Res 1991;127:308-316.
50. Chen P, Iavarone A, Fick J, Edwards M, Prados M, Israel MA. Constitutional p53 mutations associated with brain tumors in young adults. Cancer Genet Cytogenet 1995;82:106-115.
51. Hollstein M, Sidransky D, Vogelstein B, Harris CC. p53 mutations in human cancers. Science 1991;253:49-53.
52. Vogelstein B, Kinzler KW. p53 function and dysfunction. Cell 1992;70:523-6.
53. Levine AJ, Momand J, Finlay CA. The p53 tumour suppressor gene. Nature 1991;351:453-6.
54. Slichenmyer WJ, Nelson WG, Slebos RJ Kastan MB. Cancer Res 1993;53:4164-4168.
55. Krauss JA, Bolln C, Wolf HK et al. TP53 alterations and clinical outcome in low grade astrocytomas. Genes Chromosom Cancer 1994;10:143-149.
56. van Meyel DJ, Ramsay DA, Casson AG, Keeney M, Chambers AF, Cairncross JG. p53 mutation, expression, and DNA ploidy in evolving gliomas: evidence for two pathways of progression. J Natl Cancer Inst 1994;86:1011-1017.
57. Dee S, Haas-Kogan DA, Israel MA. Inactivation of p53 is associated with decreased levels of radiation-induced apoptosis in medulloblastoma cell lines. Cell Death Different 1995;2:267-275.
58. Saylors RL 3d, Sidransky D, Friedman HS et al. Infrequent p53 gene mutations in medulloblastomas. Cancer Res 1991;51:4721-4723.
59. Friedman HS, Oakes WJ, Bigner SH, Wikstrand CJ, Bigner DD. Medulloblastoma: tumor biological and clinical perspectives. J Neurooncol 1991;11:1-15.
60. Huang HJ, Yee J K, Shew JY et al. Suppression of the neoplastic phenotype by replacement of the RB gene in human cancer cells. Science 1988;242:1563-1566.